9FVE image
Deposition Date 2024-06-26
Release Date 2024-11-06
Last Version Date 2024-12-04
Entry Detail
PDB ID:
9FVE
Title:
Crystal structure of VcSiaP W73A mutant in complex with sialic acid and a VHH antibody (VHH_VcP#2)
Biological Source:
Source Organism(s):
Vicugna pacos (Taxon ID: 30538)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.81 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Sialic acid-binding periplasmic protein SiaP
Gene (Uniprot):siaP
Chain IDs:A, C, E, G, I, K, M, O, Q, T (auth: U), V (auth: W), X (auth: Y)
Chain Length:303
Number of Molecules:12
Biological Source:Vicugna pacos
Polymer Type:polypeptide(L)
Molecule:VHH_VcP#2
Chain IDs:B, D, F, H, J, L, N, P, R, S (auth: T), U (auth: V), W (auth: X)
Chain Length:123
Number of Molecules:12
Biological Source:Vicugna pacos
Primary Citation
Allosteric substrate release by a sialic acid TRAP transporter substrate binding protein.
Commun Biol 7 1559 1559 (2024)
PMID: 39580575 DOI: 10.1038/s42003-024-07263-6

Abstact

The tripartite ATP-independent periplasmic (TRAP) transporters enable Vibrio cholerae and Haemophilus influenzae to acquire sialic acid, aiding their colonization of human hosts. This process depends on SiaP, a substrate-binding protein (SBP) that captures and delivers sialic acid to the transporter. We identified 11 nanobodies that bind specifically to the SiaP proteins from H. influenzae (HiSiaP) and V. cholerae (VcSiaP). Two nanobodies inhibited sialic acid binding. Detailed structural and biophysical studies of one nanobody-SBP complex revealed an allosteric inhibition mechanism, preventing ligand binding and releasing pre-bound sialic acid. A hydrophobic surface pocket of the SBP is crucial for the allosteric mechanism and for the conformational rearrangement that occurs upon binding of sialic acid to the SBP. Our findings provide new clues regarding the mechanism of TRAP transporters, as well as potential starting points for novel drug design approaches to starve these human pathogens of important host-derived molecules.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback